Efficacy and safety of the PCSK9 inhibitor evolocumab in patients with mixed hyperlipidemia (Cardiovascular Drugs and Therapy, 2016)

(untitled) - Preiss, D; Rosenson, R; Jacobsen, T; Djedjos, C; Dent, R; Bridges, I; Miller, M